Group One Trading
LHDX

Group One Trading’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Group One Trading’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$1K – 9022
2021
Q4 		$1K Sell
100
-1,800
-95% -$11.4K ﹤0.01% 8081
2021
Q3 		$14K Sell
1,900
-14,100
-88% -$119K ﹤0.01% 7368
2021
Q2 		$106K Buy
+16,000
New +$101K ﹤0.01% 5893

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Group One Trading's LHDX Position: Q1 2023 in Review

Group One Trading sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 4,752 shares — an estimated $528 sold.

Group One Trading first reported a position in LHDX in Q2 2021 and held it in 6 quarters. The position peaked at $60K in Q1 2022. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • Group One Trading reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 4,752 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $528.
  • Group One Trading first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Group One Trading's Lucira Health, Inc. Common Stock position peaked at $60K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.